Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Quality by Design (QbD) application for the pharmaceutical development process

Full metadata record
DC Field Value Language
dc.contributor.authorLee, Sang-Ho-
dc.contributor.authorKim, Jin-Ki-
dc.contributor.authorJee, Jun-Pil-
dc.contributor.authorJang, Dong-Jin-
dc.contributor.authorPark, Young-Joon-
dc.contributor.authorKim, Joo-Eun-
dc.date.accessioned2023-02-21T05:35:53Z-
dc.date.available2023-02-21T05:35:53Z-
dc.date.issued2022-11-
dc.identifier.issn2093-5552-
dc.identifier.issn2093-6214-
dc.identifier.urihttps://scholarworks.bwise.kr/erica/handle/2021.sw.erica/111473-
dc.description.abstractBackground Quality by Design (QbD) is a pharmaceutical quality management system that predicts, controls, and systematically responds to risks that may occur in the research stage and manufacturing process. There are many articles on how to improve quality through application of the QbD system, but the methodology surrounding how to specifically apply this process is limited. The purpose of this review was to provide accurate information on drug development process and overcome the difficulties of developing QbD-applied drug products through an appropriate application method. Area covered QbD-based pharmaceuticals are continuously being developed worldwide, helping to identify potential risks, and managing all aspects, from drug design to patient consumption, further enabling the patient to be administered a high-quality drugs based on their design. In this study, a basic knowledge of QbD, its application and effectiveness during drug development will be discussed. Expert opinion Our results suggest that a QbD for drug development can reduce risk to patients, improve drug quality, and continuously produce superior quality drug products.-
dc.format.extent34-
dc.language영어-
dc.language.isoENG-
dc.publisher한국약제학회-
dc.titleQuality by Design (QbD) application for the pharmaceutical development process-
dc.title.alternativeQuality by Design (QbD) application for the pharmaceutical development process-
dc.typeArticle-
dc.publisher.location대한민국-
dc.identifier.doi10.1007/s40005-022-00575-x-
dc.identifier.scopusid2-s2.0-85140951895-
dc.identifier.wosid000847261000001-
dc.identifier.bibliographicCitationJournal of Pharmaceutical Investigation, v.52, no.6, pp 649 - 682-
dc.citation.titleJournal of Pharmaceutical Investigation-
dc.citation.volume52-
dc.citation.number6-
dc.citation.startPage649-
dc.citation.endPage682-
dc.type.docTypeReview-
dc.identifier.kciidART002896803-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.description.journalRegisteredClasskci-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.subject.keywordPlusLIFE-CYCLE MANAGEMENT-
dc.subject.keywordPlusRISK-ASSESSMENT-
dc.subject.keywordPlusFORMULATION DEVELOPMENT-
dc.subject.keywordPlusBY-DESIGN-
dc.subject.keywordPlusDRUG-DELIVERY-
dc.subject.keywordPlusTABLET FORMULATION-
dc.subject.keywordPlusTOPICAL DELIVERY-
dc.subject.keywordPlusIN-VITRO-
dc.subject.keywordPlusOPTIMIZATION-
dc.subject.keywordPlusPRODUCT-
dc.subject.keywordAuthorQuality by Design-
dc.subject.keywordAuthorPharmaceutical development process-
dc.subject.keywordAuthorQTPP-
dc.subject.keywordAuthorCQAs-
dc.subject.keywordAuthorCMAs-
dc.subject.keywordAuthorCPPs-
dc.identifier.urlhttps://link.springer.com/article/10.1007/s40005-022-00575-x-
Files in This Item
Go to Link
Appears in
Collections
COLLEGE OF PHARMACY > DEPARTMENT OF PHARMACY > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Kim, Jin-Ki photo

Kim, Jin-Ki
COLLEGE OF PHARMACY (DEPARTMENT OF PHARMACY)
Read more

Altmetrics

Total Views & Downloads

BROWSE